Cargando…
Development and Validation of four Nitrosamine Impurities Determination Method in Medicines of Valsartan, Losartan, and Irbesartan with HPLC-MS/MS (APCI)
Since 2018, regulation and control of genotoxic nitrosamine impurities levels have been a mandatory quality and safety characteristic for various drugs. The main issue of nitrosamine determination in drugs is a low sensitivity of the existing methods and a continuously extending list of controlled c...
Autores principales: | Khorolskiy, Mikhail, Ramenskaya, Galina, Vlasov, Alexander, Perederyaev, Oleg, Maslennikova, Nataliya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653666/ https://www.ncbi.nlm.nih.gov/pubmed/34904007 http://dx.doi.org/10.22037/ijpr.2021.115102.15195 |
Ejemplares similares
-
Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study
por: Eworuke, Efe, et al.
Publicado: (2023) -
Comparison of EI-GC-MS/MS, APCI-LC-MS/MS, and ESI-LC-MS/MS for the Simultaneous Analysis of Nine Nitrosamines Eluted from Synthetic Resins into Artificial Saliva and Health Risk Assessment
por: Kim, Hyungsoo, et al.
Publicado: (2021) -
Cost-effective, green HPLC determination of losartan, valsartan and their nitrosodiethylamine impurity: application to pharmaceutical dosage forms
por: Abd El-Hay, Soad S., et al.
Publicado: (2022) -
Simultaneous Determination of 15 Sulfonate Ester Impurities in Phentolamine Mesylate, Amlodipine Besylate, and Tosufloxacin Tosylate by LC-APCI-MS/MS
por: Jin, Bo, et al.
Publicado: (2019) -
Quali-Quantitative Profile of Native Carotenoids in Kumquat from Brazil by HPLC-DAD-APCI/MS
por: Pinheiro-Sant’Ana, Helena Maria, et al.
Publicado: (2019)